Diagnostic Challenges in Extrapulmonary Tuberculosis: A Single-Center Experience in a High-Resource Setting at a German Tertiary Care Center
- PMID: 40407641
- PMCID: PMC12101312
- DOI: 10.3390/idr17030039
Diagnostic Challenges in Extrapulmonary Tuberculosis: A Single-Center Experience in a High-Resource Setting at a German Tertiary Care Center
Abstract
Background/Objectives: Extrapulmonary tuberculosis accounts for a significant portion of tuberculosis cases, presenting unique diagnostic challenges due to its heterogeneous manifestations and paucibacillary nature. This study aims to fill this gap by evaluating the diagnostic outcomes and correlations between different specimen types and test results. Methods: A retrospective analysis of electronic medical records of patients diagnosed with TB between January 2013 and December 2023 was carried out. The data extracted included patient demographics, comorbidities, TB classification, specimen types, microbiological test results, and time intervals to diagnosis. Statistical analysis was applied to compare the variables between pulmonary and extrapulmonary/disseminated TB groups. Results: Most patients were male (62.4%) and born outside of Germany (74.2%). Comorbidities, such as diabetes, cardiac disease, immunosuppressed status, and HIV, were common. Among the 194 patients, 98 had pulmonary TB, and 96 had extrapulmonary/disseminated TB. A comparison of pulmonary vs. extrapulmonary TB showed that extrapulmonary TB patients had a longer diagnostic delay (p = 0.013), more symptoms (p = 0.001), and more complications (42.7% vs. 16.3%, p < 0.001). Diagnostic challenges were evident, with multiple invasive procedures required in 43.5% of the extrapulmonary TB cases. Conclusions: This study highlights the complex clinical presentation of tuberculosis, particularly in patients with extrapulmonary and disseminated forms, who experience delayed diagnosis and more complications. These challenges in diagnosing extrapulmonary TB emphasize the need for improved diagnostic strategies and early identification, especially in high-risk populations.
Keywords: Mycobacterium tuberculosis; acid-fast bacilli; complications; diagnostic challenges; disseminated tuberculosis; extrapulmonary tuberculosis.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
The Imperative Role of Xpert® Mycobacterium Tuberculosis Complex/Resistance to Rifampin (MTB/RIF) in Rapid Diagnosis of Pulmonary and Extrapulmonary Tuberculosis.Cureus. 2024 Dec 31;16(12):e76706. doi: 10.7759/cureus.76706. eCollection 2024 Dec. Cureus. 2024. PMID: 39898141 Free PMC article.
-
Comparative analysis of pediatric pulmonary and extrapulmonary tuberculosis: A single-center retrospective cohort study in Syria.Heliyon. 2024 Aug 23;10(17):e36779. doi: 10.1016/j.heliyon.2024.e36779. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39263060 Free PMC article.
-
Epidemiology of extrapulmonary and disseminated tuberculosis in a tertiary care center in Oman.Int J Mycobacteriol. 2017 Apr-Jun;6(2):162-166. doi: 10.4103/ijmy.ijmy_31_17. Int J Mycobacteriol. 2017. PMID: 28559518
-
Diagnosis of extrapulmonary tuberculosis by PCR.FEMS Immunol Med Microbiol. 2012 Oct;66(1):20-36. doi: 10.1111/j.1574-695X.2012.00987.x. Epub 2012 Jun 29. FEMS Immunol Med Microbiol. 2012. PMID: 22574812 Review.
-
Identification of Tuberculosis: A Review of the Guidelines [Internet].Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Feb 6. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Feb 6. PMID: 33074601 Free Books & Documents. Review.
References
-
- World Health Organization . Global Tuberculosis Report 2020. World Health Organization; Geneva, Switzerland: 2020.
-
- European Centre for Disease Prevention and Control . Tuberculosis. ECDC. Annual Epidemiological Report for 2022. ECDC; Solna, Sweden: 2024.
-
- Rachwal N., Idris R., Dreyer V., Richter E., Wichelhaus T.A., Niemann S., Wetzstein N., Gotsch U. Pathogen and host determinants of extrapulmonary tuberculosis among 1035 patients in Frankfurt am Main, Germany, 2008–2023. Clin. Microbiol. Infect. 2025;31:425–432. doi: 10.1016/j.cmi.2024.11.009. - DOI - PubMed
-
- Robert-Koch-Institut . Bericht zur Epidemiologie der Tuberkulose in Deutschland für 2022. Robert-Koch-Institut; Berlin, Germany: 2022. - DOI
LinkOut - more resources
Full Text Sources
Miscellaneous